“Sounds very fishy,” he wrote. But no one making the claim has provided evidence that Power’s net worth increased by $23 million during her four years at USAID. Second, the disclosures filed ...

As the world’s first drug developed through the integration of organoid models and AI, SIGX1094 represents a major advance in the treatment of DGC, a highly aggressive cancer with no approved ...

Cell-based structure-function and co-immunoprecipitation (co-IP) assays indicate InSyn1 interacts with multiple DGC components through its unique N-terminus. InSyn1 lacking this region no longer ...

Based on the mathematical models for the pathways, each reaction rate can be altered (either increased or decreased) to generate higher levels of the key WS effector (the active DGC). For example ...